EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody–Positive Adults

Erin L Templeman, Nick Thomas, Susan Martin, Diane K Wherett, Maria J Redondo, Jennifer Sherr, Alessandra Petrelli, Laura M Jacobsen, Falastin Salami, Jacqueline Lonier, Carmella Evans-Molina, Jay Sosenko und 4 weitere

Diabetes Care · 2026

DOI: 10.2337/dc26-0446 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetes Care, 2026. Verfasst von Erin L Templeman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Diabetes Mellitus, Type 1, Autoantibodies, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council (MRC), NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE HbA1c thresholds used to define dysglycemia in autoantibody-positive individuals at risk for type 1 diabetes do not account for age-related increases in HbA1c and may overestimate progression risk in adults. We evaluated whether age-adjusted HbA1c or a higher HbA1c threshold improves risk stratification across age-groups. RESEARCH DESIGN AND METHODS We analyzed 5,024 autoantibody-positive relatives (3,720 children and 1,304 adults) participating in the TrialNet Pathway to Prevention study. Age-related HbA1c effects were modeled using 6,273 adults from the population-based Exeter 10000 cohort. Progression risk was compared using the standard dysglycemia threshold (HbA1c ≥5.7% [39 mmol/mol]), age-adjusted HbA1c, and an alternative threshold of HbA1c ≥6.0% (42 mmol/mol). RESULTS Using HbA1c ≥5.7% (39 mmol/mol), children had higher 1-year progression risk than adults among single autoantibody–positive participants (38% [95% CI 28, 47] vs. 13% [7.2, 19]) and multiple autoantibody–positive participants (55% [49, 60] vs. 38% [27, 47]) (both P < 0.001). Age adjustment reduced these differences; progression risk was similar among single autoantibody–positive participants (38% [28, 47] vs. 27% [13, 39]; P = 0.32), with attenuated differences among multiple autoantibody–positive participants. An HbA1c threshold ≥6.0% (42 mmol/mol) yielded comparable progression risk between adults and children across autoantibody subgroups. In post hoc analyses, adults aged <30 years had progression risk similar to children (P = 0.1). CONCLUSIONS Age-related variation in HbA1c influences dysglycemia classification in adults at risk for type 1 diabetes. Age-adjusted HbA1c or a higher HbA1c threshold (≥6.0% [42 mmol/mol]) in adults aged ≥30 years identifies individuals with progression risk comparable to children and may improve age-specific risk stratification in prevention settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycated HemoglobinDiabetes Mellitus, Type 1AutoantibodiesAgingIslets of LangerhansDisease ProgressionRisk FactorsRetrospective StudiesHumansMaleFemaleAdolescentYoung AdultAdultChild

Substanzen

hemoglobin A1c protein, humanGlycated Hemoglobinislet cell antibodyAutoantibodies

Autor:innen und Institutionen

  • Department of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
  • Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Baylor College of Medicine, Texas Children's Hospital, Houston, TX.
  • Yale University School of Medicine, New Haven, CT.
  • Department of Clinical Sciences and Community Health, University of Milan and Pio Albergo Trivulzio, Milan, Italy.
  • Cardiac-Thoracic-Metabolic Unit, Pio Albergo Trivulzio, Milan, Italy.

ORCID-Profile: Lauric A Ferrat

Förderung

  • Medical Research Council (MRC)
  • NIH HHS
  • NIDDK NIH HHS
  • Diabetes UK
  • Randox Laboratories Ltd
  • Breakthrough T1D
  • Wellcome Trust
  • Helmsley Trust Foundation

Zitieren

APA

Templeman, E. L., Thomas, N., Martin, S., Wherett, D. K., Redondo, M. J., Sherr, J., Petrelli, A., Jacobsen, L. M., Salami, F., Lonier, J., Evans-Molina, C., Sosenko, J., Barroso, I., Oram, R. A., Sims, E. K., & Ferrat, L. A. (2026). Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody–Positive Adults. Diabetes Care. https://doi.org/10.2337/dc26-0446

Vancouver

Templeman EL, Thomas N, Martin S, Wherett DK, Redondo MJ, Sherr J, et al. Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody–Positive Adults. Diabetes Care. 2026. doi:10.2337/dc26-0446

BibTeX
@article{Templeman2026,
  author = {Templeman, Erin L and Thomas, Nick and Martin, Susan and Wherett, Diane K and Redondo, Maria J and Sherr, Jennifer and Petrelli, Alessandra and Jacobsen, Laura M and Salami, Falastin and Lonier, Jacqueline and Evans-Molina, Carmella and Sosenko, Jay and Barroso, Inês and Oram, Richard A and Sims, Emily K and Ferrat, Lauric A},
  title = {Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody–Positive Adults},
  journal = {Diabetes Care},
  year = {2026},
  doi = {10.2337/dc26-0446}
}
Kostenlos starten →